ProcuraAxisBeta
Sign inCreate Free Account
Home / Opportunities / Opportunity
PROCUREMENT OPPORTUNITY

NP47825 Multiple Sclerosis Medicines

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · compiled

Tender information last checkedLast checked 29 Sept 2026, 20:42.

Opportunity overview

Supply of multiple sclerosis medicines to NHS Scotland.

Awarded to

Amounts belong to published awards or contracts. Where several suppliers share one value, it is labelled as shared and is not a supplier-specific allocation.

Biogen Idec Ltd

Matched by exact name
Shared contract value
£48m
Awarded
Not supplied
Contract signed
8 Apr 2025
Suppliers
One of 6 awarded suppliers
Award ID
018635-2025-1
Status
active
Location
Maidenhead, UK, SL6 3UD, United Kingdom

Merck Serono Limited

Matched by exact name
Shared contract value
£48m
Awarded
Not supplied
Contract signed
8 Apr 2025
Suppliers
One of 6 awarded suppliers
Award ID
018635-2025-1
Status
active
Location
Middlesex, UKI75, TW14 8HA, United Kingdom

Orifarm UK

Matched by normalised name
Shared contract value
£48m
Awarded
Not supplied
Contract signed
8 Apr 2025
Suppliers
One of 6 awarded suppliers
Award ID
018635-2025-1
Status
active
Location
Hemel Hempstead, UK, HP2 4TZ, United Kingdom

Sandoz Ltd

Matched by exact name
Shared contract value
£48m
Awarded
Not supplied
Contract signed
8 Apr 2025
Suppliers
One of 6 awarded suppliers
Award ID
018635-2025-1
Status
active
Location
Camberley, UK, GU16 7SR, United Kingdom

Teva UK Ltd

Matched by exact name
Shared contract value
£48m
Awarded
Not supplied
Contract signed
8 Apr 2025
Suppliers
One of 6 awarded suppliers
Award ID
018635-2025-1
Status
active
Location
Castleford, UK, WF10 5HX, United Kingdom

Viatris UK Healthcare Ltd

Matched by exact name
Shared contract value
£48m
Awarded
Not supplied
Contract signed
8 Apr 2025
Suppliers
One of 6 awarded suppliers
Award ID
018635-2025-1
Status
active
Location
Hatfield, UKH23, AL10 9UL, United Kingdom

Ranbaxy (UK) Ltd

Match pending…
Shared contract value
£602.4k
Awarded
Not supplied
Contract signed
14 Apr 2025
Suppliers
One of 3 awarded suppliers
Award ID
018635-2025-2
Status
active
Location
London, UK, W4 5YE, United Kingdom

STADA UK - Thornton & Ross

Ai Match
Shared contract value
£602.4k
Awarded
Not supplied
Contract signed
14 Apr 2025
Suppliers
One of 3 awarded suppliers
Award ID
018635-2025-2
Status
active
Location
Huddersfield, UK, HD7 5JN, United Kingdom

Teva UK Ltd

Matched by exact name
Shared contract value
£602.4k
Awarded
Not supplied
Contract signed
14 Apr 2025
Suppliers
One of 3 awarded suppliers
Award ID
018635-2025-2
Status
active
Location
Castleford, UK, WF10 5HX, United Kingdom

Classification

  • CPV33600000 — Pharmaceutical products

Lots

  • Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab£49.3m
  • Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules£2.2m

Published notice details

Additional information from the published procurement release. Fields appear only when supplied by the source; check the original notice and tender documents before acting.

Scope, procedure and submissions

Id
ocds-h6vhtk-04ce06
Status
complete
Has Recurrence
No
Review Details
Economic operators should approach the contracting authority in the first instance. However, the only formal remedy is to apply to the courts: An economic operator that suffers, or is at risk of suffering, loss, or damage attributable to a breach of duty under the Public Contracts (Scotland) Regulations 2015 or the Procurement Reform (Scotland) Act 2014, may bring proceedings in the Sheriff Court or the Court of Session. The bringing of court proceedings against the Authority after the Framework Agreement has been entered into will not affect the Framework Agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the Framework Agreement has been entered into are limited to the award of damages.
Procurement Method
open
Main Procurement Category
goods
Procurement Method Details
Open procedure

Covered By

GPA

Amendments

Entry 1
Id
1
Description
Delay to ITT publish by one (1) day.

Unstructured Changes

Entry 1

Where

Label
Time limit
Section
IV.2.2

New Value

Date
10 Feb 2025, 12:00

Old Value

Date
7 Feb 2025, 12:00
Entry 2

Where

Label
Conditions for opening of tenders
Section
IV.2.7

New Value

Date
10 Feb 2025, 12:00

Old Value

Date
7 Feb 2025, 12:00

Bid Opening

Date
7 Feb 2025, 12:00

Legal basis

Id
32014L0024
Scheme
CELEX

Lot Details

Maximum Lots Bid Per Supplier
9,999,999

Techniques

Has Framework Agreement
Yes

Framework Agreement

Maximum Participants
15

Expected award period

Starts
7 Feb 2025, 12:00

Tender Period

Ends
7 Feb 2025, 12:00

Classification

Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Submission terms

Languages

en

Bid Validity Period

Duration In Days
90

Submission Method

electronicSubmission

Selection criteria

Criteria

Criterion 1
Type
suitability
Description
Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015).

Applies To

supplier
Criterion 2
Type
technical
Minimum
(a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under the Technical and Professional ability: Quality Control. AND (b) Confirmation of the existence of valid certification of BS EN ISO 9001 or equivalent. Confirmation of such certification should be included in the Qualification Envelope of the ITT under the Quality Assurance Schemes. AND (c) Confirmation that samples for tendered Goods will be supplied upon request to ensure compliance with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. Confirmation of sample provision should be provided in the Qualification Envelope of the ITT under Technical and Professional ability: Products. AND (d) A completed copy of the Bidder Climate Change Plan Template, including planned projects and actions to reduce the bidder’s carbon emissions should be provided in the Qualification Envelope of the ITT under Environmental Management Criteria. This does not need to contain calculated carbon emissions. AND (e) Confirmation that all devices tendered and associated ancillaries which are classed as medical devices will carry the appropriate declaration of conformity for the UK market and display a valid CE, CE UKNI or UKCA mark prior to the start date of the Framework Agreement should be included in the Qualification Envelope of the ITT under Technical and Professional ability: Quality Control.
Description
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender for the Framework Agreement. AND (b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent. AND (c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design. AND (d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond. AND (e) Potential Framework Participants must be able to demonstrate that all devices tendered and associated ancillaries under this Framework Agreement comply with Medical Devices Regulations 2002 (SI 2002 No 618, as amended) (UK MDR 2002) and have an appropriate declaration of conformity and display a valid CE, CE UKNI or UKCA mark.

Applies To

supplier

Lots and requirements

Entry 1
Id
2
Title
Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules to NHS Scotland. The Authority has award this Lot as a single supplier Framework Agreement per product line to three (3) Framework Participants. Full details of Goods and volumes can be found within the ITT documents.

Value

Amount
2,199,880
Currency
GBP

Renewal

Description
The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
Technical (Supply Chain)
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
810

Submission terms

Variant Policy
notAllowed
Entry 2
Id
1
Title
Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab
Status
cancelled
Has Options
No
Has Renewal
Yes
Description
Supply of glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Value

Amount
49,317,952
Currency
GBP

Renewal

Description
The Framework Agreement includes the option to extend for any number of periods, up to a maximum overall period of twenty-one (21) months, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Award criteria

Criteria

Criterion 1
Name
Technical (Supply Chain)
Type
quality
Description
5
Criterion 2
Type
price
Description
95

Contract period

Duration In Days
810

Submission terms

Variant Policy
notAllowed

Items and delivery

Item 1
Id
2
Related Lot
2

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM
Entry 3
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products
Item 2
Id
1
Related Lot
1

Delivery Location

Description
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014.

Delivery locations

Entry 1
Region
UKM
Entry 2
Region
UKM
Entry 3
Region
UKM

Additional Classifications

Entry 1
Id
33600000
Scheme
CPV
Description
Pharmaceutical products

Buyer, suppliers and contacts

Organisation 1
Id
GB-FTS-115937
Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Roles

buyer
centralPurchasingBody

Address

Region
UKM
Locality
Edinburgh
Postal Code
EH12 9EB
Country Name
United Kingdom
Street Address
1 South Gyle Crescent

Details

Classifications

Entry 1
Id
BODY_PUBLIC
Scheme
TED_CA_TYPE
Description
Body governed by public law
Entry 2
Id
07
Scheme
COFOG
Description
Health

Identifier

Legal Name
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

Contact

Name
Cameron Wright
Telephone
+44 870831908
Organisation 2
Id
GB-FTS-324
Name
Sheriff Court House

Roles

reviewBody

Address

Locality
Edinburgh
Postal Code
EH1 1LB
Country Name
United Kingdom
Street Address
27 Chambers Street

Details

Identifier

Legal Name
Sheriff Court House

Contact

Telephone
+44 1312252525
Organisation 3
Id
GB-FTS-4558
Name
Sandoz Ltd

Roles

supplier

Address

Region
UK
Locality
Camberley
Postal Code
GU16 7SR
Country Name
United Kingdom
Street Address
Frimley Business Park, Frimley

Details

Scale
large

Identifier

Legal Name
Sandoz Ltd
Organisation 4
Id
GB-FTS-111739
Name
STADA UK - Thornton & Ross

Roles

supplier

Address

Region
UK
Locality
Huddersfield
Postal Code
HD7 5JN
Country Name
United Kingdom
Street Address
Linthwaite

Details

Scale
large

Identifier

Legal Name
STADA UK - Thornton & Ross

Contact

Telephone
+44 7979935409
Organisation 5
Id
GB-FTS-58186
Name
Merck Serono Limited

Roles

supplier

Address

Region
UKI75
Locality
Middlesex
Postal Code
TW14 8HA
Country Name
United Kingdom
Street Address
5 New Square, Bedfont Lakes Business Park , Feltham

Details

Scale
large

Identifier

Legal Name
Merck Serono Limited

Contact

Telephone
+44 7423735163
Organisation 6
Id
GB-FTS-146204
Name
Orifarm UK

Roles

supplier

Address

Region
UK
Locality
Hemel Hempstead
Postal Code
HP2 4TZ
Country Name
United Kingdom
Street Address
www.orifarm.com, 10015046

Details

Scale
large

Identifier

Legal Name
Orifarm UK

Contact

Telephone
+44 7513823507
Organisation 7
Id
GB-FTS-80784
Name
Viatris UK Healthcare Ltd

Roles

supplier

Address

Region
UKH23
Locality
Hatfield
Postal Code
AL10 9UL
Country Name
United Kingdom
Street Address
Building 4, Trident Place, Mosquito Way

Details

Scale
large

Identifier

Legal Name
Viatris UK Healthcare Ltd

Contact

Telephone
+44 7586494246
Organisation 8
Id
GB-FTS-141106
Name
Biogen Idec Ltd

Roles

supplier

Address

Region
UK
Locality
Maidenhead
Postal Code
SL6 3UD
Country Name
United Kingdom
Street Address
Biogen Building 5 Foundation Park, , Roxborough Way, Maidenhead, Berkshire, England,

Details

Scale
large

Identifier

Legal Name
Biogen Idec Ltd

Contact

Telephone
+44 7860270707
Organisation 9
Id
GB-FTS-93451
Name
Teva UK Ltd

Roles

supplier

Address

Region
UK
Locality
Castleford
Postal Code
WF10 5HX
Country Name
United Kingdom
Street Address
Ridings Point, Whistler Drive, Glasshoughton

Details

Scale
large

Identifier

Legal Name
Teva UK Ltd

Contact

Telephone
+44 7780226334
Organisation 10
Id
GB-FTS-4555
Name
Ranbaxy (UK) Ltd

Roles

supplier

Address

Region
UK
Locality
London
Postal Code
W4 5YE
Country Name
United Kingdom
Street Address
Building 4, Chiswick Park, 566 Chiswick High Road

Details

Scale
large

Identifier

Legal Name
Ranbaxy (UK) Ltd

Award information

Award 1
Id
018635-2025-1
Title
Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab
Status
active

Suppliers

Supplier 1
Id
GB-FTS-4558
Name
Sandoz Ltd
Supplier 2
Id
GB-FTS-58186
Name
Merck Serono Limited
Supplier 3
Id
GB-FTS-146204
Name
Orifarm UK
Supplier 4
Id
GB-FTS-80784
Name
Viatris UK Healthcare Ltd
Supplier 5
Id
GB-FTS-141106
Name
Biogen Idec Ltd
Supplier 6
Id
GB-FTS-93451
Name
Teva UK Ltd

Related lots

1
Award 2
Id
018635-2025-2
Title
Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules
Status
active

Suppliers

Supplier 1
Id
GB-FTS-111739
Name
STADA UK - Thornton & Ross
Supplier 2
Id
GB-FTS-4555
Name
Ranbaxy (UK) Ltd
Supplier 3
Id
GB-FTS-93451
Name
Teva UK Ltd

Related lots

2

Contracts and changes

Entry 1
Id
018635-2025-1
Title
Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab
Status
active
Award ID
018635-2025-1
Date Signed
9 Apr 2025, 00:00

Value

Amount
47,968,904
Currency
GBP
Entry 2
Id
018635-2025-2
Title
Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsules
Status
active
Award ID
018635-2025-2
Date Signed
15 Apr 2025, 00:00

Value

Amount
602,376
Currency
GBP

Recorded locations

  • Buyer location · Edinburgh · UKM · EH12 9EB · United Kingdom
  • Delivery location · UKM

Notice and amendment history

1 published notice version reviewed by ProcuraAxis.

1 VERSION
  1. ocds-h6vhtk-04ce06-2025-05-02T09:05:04+01:00compiled ·